Report cover image

Plastics In Personalized Drug Delivery Systems Market Growth, Size, Trends Analysis- By Type, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Oct 24, 2025
Length 232 Pages
SKU # SPER20694524

Description

Plastics In Personalized Drug Delivery Systems Market Introduction and Overview

According to SPER Market Research, the Global Plastics In Personalized Drug Delivery Systems Market is estimated to reach USD 5.69 billion by 2034 with a CAGR 11.07%.

The report includes an in-depth analysis of the Global Plastics In Personalized Drug Delivery Systems Market, including market size and trends, product mix, Applications, and supplier analysis. The global Plastics In Personalized Drug Delivery Systems Market was valued at USD 1.99 billion in 2024 and is expected to grow at a CAGR of over 11.07% from 2025 to 2034. Continuous innovations in polymer chemistry are driving the development of advanced, biocompatible, and responsive plastics for targeted drug delivery. These materials improve drug stability, controlled release, and patient adherence, fueling market growth. The personalized drug delivery systems industry is increasingly adopting smart polymers that respond to physiological cues like pH, temperature, and enzymes, enabling precise, time-controlled release. Biodegradable and bioresorbable plastics are gaining traction, reducing the need for device retrieval. Integration with nanotechnology, such as polymeric nanoparticles and microneedle patches, is further enhancing patient-centric, next-generation therapeutic solutions.

By Type:

Polylactic acid (PLA) leads the personalized drug delivery plastics market, driven by growing regulatory focus on sustainable medical materials. As a biodegradable and bioabsorbable polymer, PLA supports environmental goals while ensuring patient safety. Its use is expanding in single-use, biocompatible drug carriers, including injectable nanoparticles, microspheres, and transdermal patches. Pharmaceutical and medical device companies are increasingly adopting PLA-based solutions to meet stringent EU and FDA biocompatibility standards. Meanwhile, poly(lactic-co-glycolic acid) (PLGA) is gaining demand for long-acting injectable therapies due to its biodegradability, controlled release, and suitability for sustained-release drugs, protein therapeutics, and vaccines.

By End Use:

The pharmaceuticals and drug delivery segment leads the personalized drug delivery plastics market, driven by the growing adoption of nano-enabled drug delivery systems. Innovations in polymeric nanocarriers, such as liposomes, dendrimers, and polymeric micelles, are enhancing drug solubility, bioavailability, and cellular uptake. Biotech companies are investing in smart polymeric matrices to improve drug encapsulation, targeted release, and patient adherence. Strategic collaborations between pharmaceutical and material science firms are accelerating the commercialization of plastic-based nano-formulations, supporting rapid market growth and meeting the rising demand for precision medicine and biologics.

Regional Insights:

Asia Pacific leads the global personalized drug delivery plastics market, driven by growing adoption of precision medicine and advancements in polymer engineering. The region's expanding pharmaceutical and biotech industries, particularly in India, Japan, and South Korea, are fostering innovations in smart, stimuli-responsive polymeric carriers for targeted and controlled drug release. Rising chronic disease prevalence, an aging population, and government-supported healthcare digitization are fueling investments in next-generation polymeric delivery technologies, including self-regulating implants and microfluidic polymer dispensers. This positions Asia Pacific as a high-growth hub for advanced drug delivery solutions.

Market Competitive Landscape:

The Plastics In Personalized Drug Delivery Systems Market is highly consolidated. Some of the market key players are Arkema, Avient Corporation, BASF SE, Celanese Corporation, Corbion, DSM, DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries, Lubrizol Corporation.

Recent Developments:

In November 2024, Avantium and SCGC expanded their collaboration to accelerate the development of PLGA polyester, a biodegradable and recyclable material. They entered a multi-year agreement to pilot PLGA production using Avantium's Volta Technology, which transforms CO2 into glycolic acid, an essential component of PLGA.
In July 2023, CD Bioparticles launched a new PLGA-based drug delivery line for in vitro and in vivo use. The biocompatible, biodegradable nanoparticles feature various surface modifications to protect drugs, enhance delivery, and improve biological interactions. The range includes Streptavidin-Coated PLGA, Functionalized PLGA, and Functionalized Fluorescent Magnetic PLGA nanoparticles.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Type, By End Use
Regions covered North America, Latin America, Asia-Pacific, Europe, Middle East & Africa

Companies Covered

Arkema, Avient Corporation, BASF SE, Celanese Corporation, Corbion, DSM, DuPont de Nemours, Inc., Eastman Chemical Company, Evonik Industries, Lubrizol Corporation.

Key Topics Covered in the Report

Global Plastics In Personalized Drug Delivery Systems Market Size (FY'2021-FY'2034)
Overview of Global Plastics In Personalized Drug Delivery Systems Market
Segmentation of Global Plastics In Personalized Drug Delivery Systems Market By Type {(Polylactic Acid (PLA), Poly(lactic-co-glycolic acid) (PLGA), Polyethylene Glycol (PEG), Polyurethane (PU), Polyether Ether Ketone (PEEK), Others)}
Segmentation of Global Plastics In Personalized Drug Delivery Systems Market By End Use (Pharmaceuticals & Drug Delivery, Medical Devices & Implants, Contract Manufacturing & Drug Formulation Services, Healthcare & Clinics, Others)
Statistical Snap of Global Plastics In Personalized Drug Delivery Systems Market
Expansion Analysis of Global Plastics In Personalized Drug Delivery Systems Market
Problems and Obstacles in Global Plastics In Personalized Drug Delivery Systems Market
Competitive Landscape in the Global Plastics In Personalized Drug Delivery Systems Market
Details on Current Investment in Global Plastics In Personalized Drug Delivery Systems Market
Competitive Analysis of Global Plastics In Personalized Drug Delivery Systems Market
Prominent Players in the Global Plastics In Personalized Drug Delivery Systems Market
SWOT Analysis of Global Plastics In Personalized Drug Delivery Systems Market
Global Plastics In Personalized Drug Delivery Systems Market Future Outlook and Projections (FY'2025-FY'2034)
Recommendations from Analyst

Table of Contents

232 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Plastics In Personalized Drug Delivery Systems Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Plastics In Personalized Drug Delivery Systems Market
7. Global Plastics In Personalized Drug Delivery Systems Market, By Type, (USD Million) 2021-2034
7.1. Polylactic Acid (PLA)
7.2. Poly(lactic-co-glycolic acid) (PLGA)
7.3. Polyethylene Glycol (PEG)
7.4. Polyurethane (PU)
7.5. Polyether Ether Ketone (PEEK)
7.6. Others
8. Global Plastics In Personalized Drug Delivery Systems Market, By End Use, (USD Million) 2021-2034
8.1. Pharmaceuticals & Drug Delivery
8.2. Medical Devices & Implants
8.3. Contract Manufacturing & Drug Formulation Services
8.4. Healthcare & Clinics
8.5. Others
9. Global Plastics In Personalized Drug Delivery Systems Market, (USD Million) 2021-2034
9.1. Global Plastics In Personalized Drug Delivery Systems Market Size and Market Share
10. Global Plastics In Personalized Drug Delivery Systems Market, By Region, 2021-2034 (USD Million)
10.1. Asia-Pacific
10.1.1. Australia
10.1.2. China
10.1.3. India
10.1.4. Japan
10.1.5. South Korea
10.1.6. Rest of Asia-Pacific
10.2. Europe
10.2.1. France
10.2.2. Germany
10.2.3. Italy
10.2.4. Spain
10.2.5. United Kingdom
10.2.6. Rest of Europe
10.3. Middle East and Africa
10.3.1. Kingdom of Saudi Arabia
10.3.2. United Arab Emirates
10.3.3. Qatar
10.3.4. South Africa
10.3.5. Egypt
10.3.6. Morocco
10.3.7. Nigeria
10.3.8. Rest of Middle-East and Africa
10.4. North America
10.4.1. Canada
10.4.2. Mexico
10.4.3. United States
10.5. Latin America
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Rest of Latin America
11. Company Profile
11.1. Arkema
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Avient Corporation
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. BASF SE
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Celanese Corporation
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Corbion
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. DSM
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. DuPont de Nemours, Inc.
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Eastman Chemical Company
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Evonik Industries
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Lubrizol Corporation
11.10.1. Company details
11.10.2 . Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us